Volume 4, Issue 14 (4-2014)                   NCMBJ 2014, 4(14): 25-30 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tabatabaei Panah A S, Akbarzadeh Najar R. Expression of cardiomyocytesANF، MLC-2a andMLC-2vgenesas endothelial cellular markers in vascular system . NCMBJ 2014; 4 (14) :25-30
URL: http://ncmbjpiau.ir/article-1-515-en.html
1Department of Biology, Islamic Azad University, East Tehran Branch, Tehran, Iran , tabatabaeipanah@gmail.com
Abstract:   (11827 Views)
Aim and Background: The hESCs can differentiate in vitro into spontaneously contracting cardiomyocytes and produce a model to investigate the early developmental stages of this system.Cardiomyocytes derived from human embryonic stem cells (hESCs) could be useful in restoring heart function after myocardial infarction or in heart failure. In this study, three cardiomyocite genes as endothelial cellular markers in vascular system were investigated. 
Materials and Methods: After stem cell culture,the expression pattern ANF،MLC-2a and MLC-2vwere analyzed by reverse transcriptase-polymerase chain reaction (RT-PCR). 
Results: There was an enhanced expression of as myosin light chain atrial (MLC-2a) from day 15 and day 20 in EB. The myosin light chain ventricular (MLC-2v) and (ANF), atrial natriuretic gene expression were significantly increased sequentially by day45 and 20. 
Conclusion: hESCs might be useful as an effective model system for understanding the developmental processes and functioning of the human heart.
Full-Text [PDF 340 kb]   (2880 Downloads)    
Type of Study: Research Article | Subject: Cellular and molecular
Received: 2014/07/12 | Accepted: 2014/07/12 | Published: 2014/07/12

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb